Here’s why Powell’s Fed policy comments reinforced Cramer’s stance on owning quality companies

Business News

CNBC’s Jim Cramer said Wednesday he believes the current investing paradigm remains intact after Federal Reserve Chairman Jerome Powell’s comments on inflation and central bank policy earlier in the day.

“If you’re buying companies that make and sell valuable things for a nice profit and return some of those profits to shareholders, I think you’re going to do just fine,” the “Mad Money” host said.

“If you’re still buying companies that make no money but grow fast, you won’t do fine at all because Powell is not on that team anymore,” Cramer continued, repeating an investing mantra he’s championed since late last year in response to the Fed starting to tighten policy.

You Might Like

While Cramer acknowledged Powell sounded more hawkish at times Wednesday, he contended that traders who sold stocks during his afternoon press conference weren’t necessarily right to do so.

“If your company can still make things and sell them at a profit in a rising interest rate environment … don’t let these high-speed sell programs scare you away from value,” Cramer said.

The former hedge fund manager said even though the Fed is unwinding its highly accommodative policy, “that doesn’t mean everything’s bad.”

“It merely means there are fewer ideas that are good. They still exist, though, you just have to know where to find them,” Cramer said.

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money TwitterJim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com

Articles You May Like

PBS: AZ Abortion Ban Dates to When Slavery Was Legal and Only White Men Could Vote
Clark and Reese dazzle on the court, but WNBA politics kill the game
Tim Scott: Biased Lawfare Pushes Black Voters to Trump
A citizen’s guide to FBI ‘knock and talks’
Most doses of Eli Lilly’s Zepbound, Mounjaro in short supply through June, FDA says 

Leave a Reply

Your email address will not be published. Required fields are marked *